Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,065.00
Bid: 4,060.00
Ask: 4,061.00
Change: 38.00 (0.94%)
Spread: 1.00 (0.025%)
Open: 4,049.00
High: 4,077.00
Low: 4,022.00
Prev. Close: 4,027.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First quarter trading statement

26 Apr 2012 07:00

RNS Number : 0818C
Croda International PLC
26 April 2012
 



26 April 2012

 

Croda International Plc

 

First quarter trading statement

 

STRONG START TO 2012

 

 

Martin Flower, Chairman of Croda International Plc, is due to provide the following update on first quarter trading for the period ended 31 March 2012 at today's Annual General Meeting:

 

"I am pleased to report that we achieved record Group results in the first three months of 2012, driven by our highest ever quarterly sales and profits in both Consumer Care and Performance Technologies.

 

Group sales from continuing operations increased 4.7% to £291.0m (2011: £277.9m). We achieved sales growth in all the major geographical areas in which we operate and volumes were much improved versus the run rates seen during the second half of 2011. Group operating profit from continuing operations was up 8.0% to £65.8m (2011: £60.9m).

 

Group pre-tax profit from continuing operations increased 7.2% to £65.1m (2011: £60.7m).

 

All business areas within Consumer Care saw very good growth, resulting in a sales uplift of 9.2% to £159.7m (2011: £146.3m) and a 13.7% increase in operating profit to £48.2m (2011: £42.4m). Return on sales was 30.2%.

 

Performance Technologies sales increased by 2.9% to £106.9m (2011: £103.9m), in line with expectations, and operating profit increased by 1.2% to £16.3m (2011: £16.1m). Return on sales was 15.2%. This was an encouraging result against very strong comparatives in the first quarter of 2011 when we experienced profit growth of 56.3%.

 

In Industrial Chemicals, which represents less than 2% of Group operating profit, sales fell by 11.9% to £24.4m (2011: £27.7m) due to slow demand in Europe. This led to a 45.8% fall in operating profit to £1.3m (2011: £2.4m).

 

Raw material costs have started to rise and we began to introduce price increases across a number of product areas from April.

 

Strong cash generation and a final receipt of £15.9m from the 2008 sale of our Chicago business reduced net debt by £45.2m to £185.9m (year end 2011: £231.1m).

 

The Board believes that these results represent a strong start to the year and we remain confident that 2012 will be another year of progress for Croda."

 

For further information, please contact:

 

Steve Foots, Group Chief Executive

Tel: 01405 860551

Sean Christie, Group Finance Director

Ben Foster, Pendomer Communications

Tel: 020 3603 5220

 

The company will host a conference call for analysts at 8.00am (BST) today:

Dial-In: 020 3140 0724

Please quote "Croda International"to gain access to the call

 

 

Croda International Plc

Unaudited income statement before tax and exceptional items

 

 

31 March 2012

3 months to

3 months to

31 March

31 March

2012

2011

Change

Consumer Care

159.7

146.3

+9.2%

Performance Technologies

106.9

103.9

+2.9%

Industrial Chemicals

24.4

27.7

-11.9%

Revenues from continuing operations

291.0

277.9

+4.7%

Consumer Care

48.2

42.4

+13.7%

Performance Technologies

16.3

16.1

+1.2%

Industrial Chemicals

1.3

2.4

-45.8%

Operating profit from continuing operations

65.8

60.9

+8.0%

Net bank and loan interest payable

(1.9)

(2.0)

Net retirement benefit scheme financing

1.2

1.8

Profit before tax from continuing operations

65.1

60.7

+7.2%

Operating margin

22.6%

21.9%

 

Analysis of turnover uplift for continuing operations

Volume

-1.5%

Currency impact

-0.2%

Price/mix

+6.4%

+4.7%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIAMFTMBMTBLT
Date   Source Headline
7th Apr 20217:00 amRNSCroda acquires fragrance business Parfex
6th Apr 20216:06 pmRNSDirector/PDMR Shareholding
1st Apr 20216:30 pmRNSDirector/PDMR Shareholding
30th Mar 20215:13 pmRNSDirector/PDMR Shareholding
25th Mar 202111:11 amRNSWebinar launch Croda’s Sustainability Report 2020
25th Mar 202110:55 amRNSAnnual Financial Report
24th Mar 20213:12 pmRNSDirector/PDMR Shareholding
23rd Mar 202111:07 amRNSDirector/PDMR Shareholding
22nd Mar 202111:54 amRNSDirector/PDMR Shareholding
17th Mar 20214:37 pmRNSDirector/PDMR Shareholding
17th Mar 20214:35 pmRNSDirector/PDMR Shareholding
17th Mar 20214:32 pmRNSDirector/PDMR Shareholding
17th Mar 20214:31 pmRNSDirector/PDMR Shareholding
17th Mar 20214:30 pmRNSDirector/PDMR Shareholding
17th Mar 20214:29 pmRNSDirector/PDMR Shareholding
17th Mar 20214:28 pmRNSDirector/PDMR Shareholding
17th Mar 20214:27 pmRNSDirector/PDMR Shareholding
17th Mar 20214:23 pmRNSDirector/PDMR Shareholding
17th Mar 20214:23 pmRNSDirector/PDMR Shareholding
17th Mar 20214:22 pmRNSDirector/PDMR Shareholding
17th Mar 20214:19 pmRNSDirector/PDMR Shareholding
11th Mar 20213:25 pmRNSDirector/PDMR Shareholding
2nd Mar 20217:02 amRNSCroda acquires Alban Muller
2nd Mar 20217:00 amRNSFinal Results
11th Feb 20213:12 pmRNSDirector/PDMR Shareholding
12th Jan 20215:26 pmRNSDirector/PDMR Shareholding
30th Dec 20205:07 pmRNSDirector/PDMR Shareholding
11th Dec 20203:33 pmRNSDirector/PDMR Shareholding
30th Nov 20208:57 amRNSTotal Voting Rights
24th Nov 202012:52 pmRNSCroda completes acquisition of Iberchem
24th Nov 202010:39 amRNSDirector/PDMR Shareholding
24th Nov 202010:38 amRNSDirector/PDMR Shareholding
18th Nov 20205:30 pmRNSCroda International
18th Nov 20203:54 pmRNSResults of the Placing
18th Nov 20207:01 amRNSRetail Offer via PrimaryBid.com
18th Nov 20207:00 amRNSAcquisition of Iberchem
11th Nov 20204:50 pmRNSDirector/PDMR Shareholding
10th Nov 20201:41 pmRNSCOVID-19 vaccine contract
2nd Nov 20203:35 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:29 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:24 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:21 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSVirtual investor seminar on sustainability
13th Oct 20204:57 pmRNSDirector/PDMR Shareholding
5th Oct 20202:42 pmRNSDirector/PDMR Shareholding
11th Sep 20203:39 pmRNSDirector/PDMR Shareholding
11th Sep 20209:48 amRNSDirector/PDMR Shareholding
13th Aug 20207:00 amRNSCroda completes acquisition of Avanti Polar Lipids
11th Aug 20204:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.